# A Trial of the ALK Grass Tablet in Subjects With Hayfever

> **NCT00227279** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 634 (actual)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** ALK Grass tablet

## Key facts

- **NCT ID:** NCT00227279
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2013-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227279, "A Trial of the ALK Grass Tablet in Subjects With Hayfever". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00227279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*